Attend Supported Sessions at APHON

This year, APHON has several great Non-CNE and CNE Satellite Symposia presentations from our supporters. Their support allows APHON to continue to host the Annual Conference each year. Please consider attending these industry sessions.

To RSVP for a session, add the symposia sessions you wish to attend on the optional events page in your registration process. You can also call an APHON member service representative at 855.202.9760 (US Residents) or 847.375.4724. to add a Satellite Symposia session to your registration.

By registering for a Satellite Symposia event, you authorize APHON to share your contact information (name, phone, and email address) with the symposia sponsor.

Wednesday, October 27
12:00 – 1:15 pm

Non-CNE Symposium: Nursing Considerations for Asparlas®: A More Stable Pegylated Asparaginase Molecule (SYM7)

Attend this symposium to learn about:

  • Review the clinical efficacy profile of Asparlas®
  • Explore a patient profile to help identify patients who may be appropriate for treatment with Asparlas.
  • Discuss the clinical safety profile, adverse reaction management, and important safety information for Asparlas.


We thank Servier for their generous support of this event.

6:00 – 7:15 pm
Wednesday, October 27

Non-CE Satellite Symposia: Case Study: VOD with Renal and Pulmonary Dysfunction Following HSCT in a Pediatric Patient With Neuroblastoma (SYM3)

Join us for a real-world case-based discussion of veno-occlusive disease (VOD) following hematopoietic stem-cell transplantation (HSCT). Topics include identifying factors that put patients at a greater risk for VOD, recognizing the signs and symptoms of VOD, and reviewing recently published diagnostic criteria in order to help make an early and accurate diagnosis of VOD.



We thank Jazz Pharmaceuticals for their generous support of this event.

10:15 – 11:15 am
Thursday, October 28

The Silent Damage of Iron Overload: Best Practices for Optimal Chelation in Transfused Patients With Sickle Cell Disease or Thalassemia (SYM2)

Understanding iron overload and the importance of chelation therapy in transfused patients with sickle cell disease or thalassemia is critical. A nurse expert will review best practices for helping patients achieve optimal chelation and why regular kidney assessment matters and a patient with sickle cell disease will share the real-world experience.© CHIESI USA, Inc. 2021. All rights reserved.
PP-F-0136 V1.0 April 2021

Chiesi homepage

APHON thanks Chiesi for their generous support of this event.

4:45 – 6:00 pm
Friday, October 29

Discover A Different Treatment for Pediatric Patients with Hemophilia A (SYM4)

Please join us for an engaging symposium led by expert Jennifer Maahs, NP, to learn more about hemophilia A and a subcutaneous treatment option for pediatric patients. She will discuss using a different prophylaxis option, share key clinical data, and answer your questions! This symposium is sponsored by Genentech, Inc.

Genetech homepage

We thank Genetech for their generous support of this event.

7:30 – 8:45 am
Saturday, October 30

Recognition Session for Certified Oncology Nurses: The Secret Sauce . . . Thriving in Times of Change (RB)

A great deal has changed since Covid 19 arrived on the scene. In addition to the health threat, virtually every aspect of daily life and routine has also been disrupted. As if our pre-Covid challenges were not enough! So how can we be at our best, even in the face of all the change and uncertainty? Well, one thing we do know for certain:

Now — more than ever — we need a reason to Laugh!

Meg’s presentation will celebrate the accomplishments of Oncology Nurses and related specialties after a year when they were called upon to adapt in an environment where no one knew what to expect next! Using experiences from her career as an Operating Room nurse, she will share ideas about how we can harness our mental energy to bolster our resilience and strengthen relationships with those around us so we can be at our best even when pushed to our limits – all delivered with her trademark humor.

This presentation will entertain, inspire, and provide those attending with tools they can use to bolster their resilience, self-awareness, and interpersonal relationships.


*Please note that while this optional event is included in the conference fee, selecting the event on the registration form is required to attend. Space is limited to the first 300 certified hematology/oncology/BMT nurses who register.

oncc homepage

APHON thanks ONCC for their generous support of this event. 
Meg Soper
12:45 pm – 2:00 pm
Saturday, October 30

Acute Lymphoblastic Leukemia: Nursing Notes on Asparaginase Hypersensitivity and Silent Inactivation (SYM6 )

Attendees will gain a greater insight into the critical position of the pediatric oncology nurse in monitoring for and managing both ASNase hypersensitivity and the inactivation process which may occur during treatment and be prepared to provide effective education to patients with ALL and their families concerning these issues.

Nursing Credit

MediCom Worldwide, Inc. is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 1.0 contact hour. Program Number: 21-038-148


medicom homepage1

Provided by MediCom Worldwide, Inc. This activity is supported by educational grants from Jazz Pharmaceuticals and Servier Pharmaceuticals LLC.